Muthusamy Shanmugam net worth and biography

Muthusamy Shanmugam Biography and Net Worth

Head of R&D and COO of NJ Operations of ANI Pharmaceuticals

Mr. Shanmugam is ANI’s Head of Research & Development and Chief Operating Officer of New Jersey Operations and a member of ANI’s Board. Mr. Shanmugam joined the Board in November 2021 in connection with ANI's acquisition of Novitium Pharma, where he was the President and Founder. Mr. Shanmugam has over three decades of experience in the pharmaceutical industry, most recently serving as President of Novitium from 2016 to November 2021. Mr. Shanmugam began his career as a formulation scientist at Kali Laboratories, Inc. and grew to become a leading formulation development scientist in the generic drug industry. Prior to co-founding Novitium, Mr. Shanmugam also held positions at Par Pharmaceutical, Inc. and Novel Laboratories, Inc. Mr. Shanmugam is a director and founder of Nuray Chemicals Private Limited and Sthree Chemicals Private Limited, both located in India and engaged in manufacturing of active pharmaceutical ingredients, and is a director and founder of SS Pharma LLC, which acts as a U.S. agent for sales of active pharmaceutical ingredients. Mr. Shanmugam is also a director and founder of Scitus Pharma Services Pvt Ltd, a clinical research organization also located in India. Mr. Shanmugam obtained his M.S. in Industrial Pharmacy from the Tamil Nadu Dr. M.G.R. Medical University and is a registered pharmacist in the state of New York.

What is Muthusamy Shanmugam's net worth?: The estimated net worth of Muthusamy Shanmugam is at least $42.96 million as of July 17th, 2024. Mr. Shanmugam owns 635,363 shares of ANI Pharmaceuticals stock worth more than $42,956,892 as of March 30th. This net worth evaluation does not reflect any other investments that Mr. Shanmugam may own. Learn More about Muthusamy Shanmugam's net worth.
How old is Muthusamy Shanmugam?: Mr. Shanmugam is currently 56 years old. There are 8 older executives and no younger executives at ANI Pharmaceuticals. The oldest executive at ANI Pharmaceuticals is Mr. James G. Marken, Senior Vice President of Operations, who is 61 years old. Learn More on Muthusamy Shanmugam's age.
How do I contact Muthusamy Shanmugam?: The corporate mailing address for Mr. Shanmugam and other ANI Pharmaceuticals executives is 210 Main Street West, Baudette MN, 56623. ANI Pharmaceuticals can also be reached via phone at (218) 634-3500 and via email at ir@anipharmaceuticals.com. Learn More on Muthusamy Shanmugam's contact information.
Has Muthusamy Shanmugam been buying or selling shares of ANI Pharmaceuticals?: Muthusamy Shanmugam has not been actively trading shares of ANI Pharmaceuticals within the last three months. Most recently, Muthusamy Shanmugam sold 14,257 shares of the business's stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $63.16, for a transaction totalling $900,472.12. Following the completion of the sale, the chief operating officer now directly owns 635,363 shares of the company's stock, valued at $40,129,527.08. Learn More on Muthusamy Shanmugam's trading history.
Who are ANI Pharmaceuticals' active insiders?: ANI Pharmaceuticals' insider roster includes Stephen Carey (CFO), Stephen Carey (Senior Vice President, Finance and Chief Financial Officer), Meredith Cook (Senior Vice President, General Counsel and Corporate Secretary), Krista Davis (Senior Vice President and Chief Human Resources Officer), Chad Gassert (Senior Vice President, Corporate Development and Strategy), Ori Gutwerg (Senior Vice President, Generics), Thomas Haughey (Director), Nikhil Lalwani (Pres), Nikhil Lalwani (President and Chief Executive Officer), James Marken (Senior Vice President, Operations and Product Development), Christopher Mutz (Insider), Antonio Pera (Director), Muthusamy Shanmugam (Head of R&D and COO of NJ Operations), Muthusamy Shanmugam (Head of R&D and COO), Renee Tannenbaum (Director), Jeanne Thoma (Director), and Patrick Walsh (Director). Learn More on ANI Pharmaceuticals' active insiders.
Are insiders buying or selling shares of ANI Pharmaceuticals?: During the last year, insiders at the specialty pharmaceutical company sold shares 33 times. They sold a total of 268,126 shares worth more than $16,946,714.15. The most recent insider tranaction occured on March, 13th when VP Meredith Cook sold 400 shares worth more than $25,332.00. Insiders at ANI Pharmaceuticals own 12.7% of the company. Learn More about insider trades at ANI Pharmaceuticals.
Information on this page was last updated on 3/13/2025.

Muthusamy Shanmugam Insider Trading History at ANI Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/17/2024	Sell	14,257	$63.16	$900,472.12	635,363
7/15/2024	Sell	11,000	$63.38	$697,180.00	671,620
6/21/2024	Sell	20,000	$58.90	$1,178,000.00	682,620
5/20/2024	Sell	12,855	$61.81	$794,567.55	732,620
5/17/2024	Sell	5,836	$62.09	$362,357.24	745,475
5/15/2024	Sell	14,850	$65.86	$978,021.00	767,770
4/19/2024	Sell	16,809	$65.17	$1,095,442.53	782,620
4/17/2024	Sell	9,520	$65.40	$622,608.00	809,852
4/15/2024	Sell	7,414	$66.33	$491,770.62	825,206
3/7/2024	Sell	15,085	$66.35	$1,000,889.75	842,620
3/5/2024	Sell	10,093	$65.35	$659,577.55	872,527
1/22/2024	Sell	5,692	$55.95	$318,467.40	897,620
1/18/2024	Sell	9,784	$55.30	$541,055.20	907,836
1/16/2024	Sell	5,000	$55.63	$278,150.00	927,620
12/18/2023	Sell	13,026	$52.44	$683,083.44	957,620
12/15/2023	Sell	11,974	$52.44	$627,916.56	970,646
11/16/2023	Sell	6,448	$51.66	$333,103.68	996,430
11/14/2023	Sell	22,095	$53.17	$1,174,791.15	1,010,525
10/18/2023	Sell	6,242	$57.78	$360,662.76	1,042,620
10/16/2023	Sell	13,063	$58.31	$761,703.53	1,057,620
10/13/2023	Sell	11,937	$57.58	$687,332.46	1,070,683
9/18/2023	Sell	8,425	$61.64	$519,317.00	1,107,953
9/15/2023	Sell	16,242	$62.81	$1,020,160.02	1,116,378
8/28/2023	Sell	25,000	$63.06	$1,576,500.00	1,157,620
8/14/2023	Sell	27,890	$61.15	$1,705,473.50	1,204,730
7/21/2023	Sell	11,500	$52.56	$604,440.00	1,232,620
7/19/2023	Sell	5,969	$51.48	$307,284.12	1,250,120
7/17/2023	Sell	9,831	$51.06	$501,970.86	1,262,789
7/14/2023	Sell	10,000	$50.43	$504,300.00	1,272,620
6/22/2023	Sell	13,500	$51.38	$693,630.00	7,407
6/20/2023	Sell	14,657	$51.93	$761,138.01	32,750
3/17/2022	Buy	5,000	$27.65	$138,250.00

See Full Table

Muthusamy Shanmugam Buying and Selling Activity at ANI Pharmaceuticals

ANI Pharmaceuticals Company Overview

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Today's Range

Now: $67.61

$67.02

$68.49

50 Day Range

MA: $60.49

$54.51

$68.36

2 Week Range

Now: $67.61

$52.50

$70.00

Volume

355,964 shs

Average Volume

256,304 shs

Market Capitalization

$1.47 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.63

Muthusamy Shanmugam Biography and Net Worth

What is Muthusamy Shanmugam's net worth?

How old is Muthusamy Shanmugam?

How do I contact Muthusamy Shanmugam?

Has Muthusamy Shanmugam been buying or selling shares of ANI Pharmaceuticals?

Who are ANI Pharmaceuticals' active insiders?

Are insiders buying or selling shares of ANI Pharmaceuticals?